Ely Benaim is a Chief Medical Officer at Henlius USA Inc.. He possess expertise in clinical trials, clinical development, oncology, biotechnology, clinical research and 32 more skills. Colleagues describe him as "Dr. Benaim was instrumental in securing my recruitment services and to whom I reported at Sangamo BioSciences about my staffing activities for Clinical Research Associates and Regulatory personnel. Ely is a creative manager of people and operations, and an insightful and forward-thinking decision-maker.", "I worked directly with Ely at Salmedix as we prepared the commercial pathway for TREANDA, now a market leader in the lymphoma area. He is a strong and motivated leader with outstanding skills in relations with KOLs. Ely possesses a strong medical and scientific acumen combined with a keen sense for creating commercial value. Ely is a great partner and would be a great addition to any leadership team.", and "Ely possess the leadership, technical and business attributes one desires in a C level executive. As a highly competent medical professional that has worked in the clinical arena Ely was able to obtain the cooperation of Key Opinion Leaders, the physicians and researchers, that we needed to obtain to move our clinical trials forward. Throughout the trials Ely worked seamlessly with both external clinical and internal team members to drive forward the trials. His enthusiasm and energy level inspired and invigorated many team members that either thrived off the leadership or calmed the doubts of others when internal events or preliminary data may not appear as well as expected. He also clearly understands the macro business environment and focuses his team's efforts in achieving our company's goals. He works well and makes a strong effort in learning other team members' responsibilities in marketing, regulatory, operations as well as others. It was a pleasure working with Ely and I would look forward to doing so if our business paths meet again."